Cite
HARVARD Citation
Funakoshi, Y. et al. (2022). Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer. Journal of infection and chemotherapy. 28 (4), pp. 516-520. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Funakoshi, Y. et al. (2022). Safety and immunogenicity of the COVID-19 vaccine BNT162b2 in patients undergoing chemotherapy for solid cancer. Journal of infection and chemotherapy. 28 (4), pp. 516-520. [Online].